Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 91,874 | 189,660 | 68,387 | -21,061 | -130,020 |
| Depreciation Amortization | 9,250 | 4,406 | 24,839 | 66,835 | 78,015 |
| Income taxes - deferred | -5,677 | 10,242 | -21,909 | N/A | N/A |
| Accounts receivable | 581 | 12,450 | 4,711 | 9,092 | 4,301 |
| Accounts payable and accrued liabilities | 2,170 | -1,347 | -7,176 | -4,585 | 10,750 |
| Other Working Capital | 70,649 | -10,187 | -19,248 | -5,655 | 30,824 |
| Other Operating Activity | 15,453 | -18,270 | 30,545 | 22,347 | 84,900 |
| Operating Cash Flow | $184,300 | $186,954 | $80,149 | $66,973 | $78,770 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -39 | 506,232 | -73,835 | -36,249 |
| Purchase Of Investment | -46,668 | 0 | -15,000 | -134,588 | -384,206 |
| Sale Of Investment | 9,772 | 15,000 | 70,778 | 291,083 | 308,759 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -16,027 |
| Other Investing Activity | 0 | 3,469 | 24,805 | -10,005 | -4,296 |
| Investing Cash Flow | $-36,896 | $18,430 | $586,815 | $72,655 | $-115,992 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 82,039 | 0 | 0 | 2,118 | N/A |
| Debt Repayment | -203,977 | -69,953 | -667 | -7,394 | -675 |
| Common Stock Issued | N/A | 287,148 | 15,390 | 27,273 | 33,529 |
| Dividend Paid | -130,043 | -319,020 | -912,580 | N/A | N/A |
| Other Financing Activity | 12,924 | 70,610 | 19,317 | 0 | 0 |
| Financing Cash Flow | $-239,057 | $-31,215 | $-878,540 | $21,997 | $32,854 |
| Beginning Cash Position | 303,227 | 129,058 | 340,634 | 179,009 | 183,377 |
| End Cash Position | 211,574 | 303,227 | 129,058 | 340,634 | 179,009 |
| Net Cash Flow | $-91,653 | $174,169 | $-211,576 | $161,625 | $-4,368 |
| Free Cash Flow | |||||
| Operating Cash Flow | 184,300 | 186,954 | 80,149 | 66,973 | 78,770 |
| Capital Expenditure | N/A | -39 | -3,273 | -94,738 | -36,518 |
| Free Cash Flow | 184,300 | 186,915 | 76,876 | -27,765 | 42,252 |